Skip to main content
. 2018 Jul 16;2:PO.17.00263. doi: 10.1200/PO.17.00263

Fig 2.

Fig 2.

(A) Treatment history of patient 2. (B) Computed tomography images of the patient’s liver metastases (top) and lung mass (bottom) during treatment. (C) Results of tissue genotyping with SNaPshot next-generation sequencing (NGS) panel on days −29, 60, 61, and 68 and Guardant360 plasma test (mutant allele frequencies [MAFs] in parentheses) on day 57. (D) Serial circulating tumor DNA (ctDNA) droplet digital polymerase chain reaction (ddPCR) results during treatment.